BridgeMD
New treatment option for Pulmonary Rehabilitation
Official title Pulmonary Rehabilitation in Advanced Non-small Cell Lung Cancer Patients
ClinicalTrials.gov ID: NCT02978521
What this study is testing
- What it's testing
- Lung cancer (LC) is usually diagnosed in advanced stages and continues to be the leading cause of cancer related deaths worldwide. Cancer cachexia are frequent among patients with LC affecting up to 80% of patients with advanced stage disease, and it has been related with higher risk of complications, length of hospital stay, and worst overall survival.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Confirmed diagnosis of advanced non-small-cell lung cancer
- Good performance status (ECOG 0-1)
- Life expectancy \>12 weeks
- Eligible to receive treatment with chemotherapy or tyrosinkinase inhibitors
- Recent electrocardiogram without evidence of arrythmia
You likely can't join if
- Symptomatic brain metastasis
- Uncontrolled pain (Visual Analog Scale \>5)
- Uncontrolled hypertension (\>140/100mmHg)
- Practice of regular moderate to intense physical activity at least 3 day/week
- Not residents of Mexico City or unable to attend to therapy sessions
The study team makes the final eligibility decision.
Where it's taking place
- Mexico City, Mexico City, Mexico
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Mexico City, Mexico City, Mexico. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.